306 / 464
306
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
ELECTRONIC POSTERS
S. Ruiz Arrebola (Spain), A.M. Tornero-López, J.M. De la Vega, P.J. Prada,
D. Guirado
EP-1768
> Hypofractionated EBRT and single fraction HDR brachytherapy for
patients with prostate cancer.
D.E. Kazberuk (Poland), T.M. Filipowski, A. Szmigiel-Trzcińska, M. Niksa,
D. Hempel, J. Topczewska-Bruns, W. Nowik, B. Pancewicz-Janczuk
EP-1769
> Unpredictable PSA failure in intermediate-risk prostate cancer after
seed implant brachytherapy
K. Kikuchi (Japan), R. Nakamura, H. Kakuhara, S. Yamaguchi,
H. Oikawa, W. Obara, H. Ariga
EP-1770
> Low dose rate brachytherapy for prostate cancer: A Brazilian Institution
experience.
E.T.T. Leite (Brazil), J.L.F.D. Silva, E. Capelletti, G.N. Marta
EP-1771
> HDR Brachytherapy in the treatment of prostate cancer – the Vienna
Experience
O. Komina (Austria), C. Seitz-Kästner, J. Hofbauer, M. Kuntner,
J. Wimmer, T. Knocke-Abulesz, E. Nechvile
EP-1772
> Clinical outcomes in localised prostate cancer treated with HDR
Brachytherapy as single fraction
L. Larrea (Spain), E. López-Muñoz, P. Antonini, V. Gonázlez,
M.C. Baños, J. Bea, M.A. García
EP-1773
> Randomized phase II trial of IGRT with or without HDR boost in
intermediate-risk prostate cancer
E. Vigneault (Canada), G. Morton, W. Perulekar, T. Niazi, G. Springer,
M. Barkati, P. Chung, W. Koll, A. Kamran, M. Montreal, K. Ding,
A. Loblaw
EP-1774
> Acute toxicity in early cancer prostate patients: low dose rate vs high
dose rate monotherapy
S. Rodríguez Villalba (Spain), A. Otal Palacín, J. Richart Sanchez,
J. Pérez-Calatayud, M. Santos Ortega
EP-1775